MPM BioVentures 2018 GP LLC, 10% Owner at iTeos Therapeutics, Inc. (ITOS), sold 182,508 shares at $27.03 ($5.2M) on 2021-09-20, disclosed to the SEC on 2021-09-20.
Scheduled sale ($5.2M) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.47 | 21,253 | $605K | 11.7% |
| 2 | $28.47 | 21,253 | $605K | 11.7% |
| 3 | $28.82 | 45,698 | $1.3M | 25.4% |
| 4 | $28.82 | 45,698 | $1.3M | 25.4% |
| 5 | $27.03 | 10,602 | $287K | 5.5% |
| 6 | $27.03 | 10,602 |
| $287K |
| 5.5% |
| 7 | $27.84 | 13,701 | $381K | 7.4% |
| 8 | $27.84 | 13,701 | $381K | 7.4% |
| Total | $28.38 avg | 182,508 | $5.2M | 100% |
| Filing → |
| ITOS | SELL | 2022-01-06 | $12.5M | — | Filing → |
| ITOS | SELL | 2021-10-18 | $939K | — | Filing → |
| ITOS | SELL | 2021-10-14 | $2.3M | — | Filing → |